Search research articles
Contact Us
Filters
Showing results (461-470 of 496) with videos related to
Page
of 50
Sort By:
Journal of Medicinal Chemistry
|
May 26, 2006
Discovery of proline sulfonamides as potent and selective hepatitis C virus NS5b polymerase inhibitors. Evidence for a new NS5b polymerase binding site
Ariamala Gopalsamy, Rajiv Chopra, Kitae Lim, et al.
Molecular Cancer
|
May 21, 2010
NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations
Yi-Ping Fu, Hege Edvardsen, Alpana Kaushiva, et al.
The Journal of the Acoustical Society of America
|
October 15, 2013
The North Pacific Acoustic Laboratory deep-water acoustic propagation experiments in the Philippine Sea
Peter F Worcester, Matthew A Dzieciuch, James A Mercer, et al.
Nature Communications
|
January 30, 2015
Probing electric field control of magnetism using ferromagnetic resonance
Ziyao Zhou, Morgan Trassin, Ya Gao, et al.
Neurology
|
August 11, 2021
Pure Motor Onset and IgM-Gammopathy Occurrence in Multifocal Acquired Demyelinating Sensory and Motor Neuropathy
Grayson Beecher, Shahar Shelly, P James B Dyck, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
|
January 18, 2019
A systematic, deep sequencing-based methodology for identification of mixed-genotype hepatitis C virus infections
Andrea D Olmstead, Vincent Montoya, Celia K Chui, et al.
Scientific Reports
|
January 15, 2014
Quantification of strain and charge co-mediated magnetoelectric coupling on ultra-thin Permalloy/PMN-PT interface
Tianxiang Nan, Ziyao Zhou, Ming Liu, et al.
Scientific Reports
|
September 2, 2016
Non-Volatile Ferroelectric Switching of Ferromagnetic Resonance in NiFe/PLZT Multiferroic Thin Film Heterostructures
Zhongqiang Hu, Xinjun Wang, Tianxiang Nan, et al.
Lancet (London, England)
|
December 4, 2014
Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial
Eric Lawitz, Edward Gane, Brian Pearlman, et al.
Lancet (London, England)
|
December 4, 2014
Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial
Mark Sulkowski, Christophe Hezode, Jan Gerstoft, et al.
Page
of 50
Search research articles
Search
Showing results (461-470 of 496) with videos related to
Sort By:
Page
of 50
Journal of Medicinal Chemistry
|
May 26, 2006
Discovery of proline sulfonamides as potent and selective hepatitis C virus NS5b polymerase inhibitors. Evidence for a new NS5b polymerase binding site
Ariamala Gopalsamy, Rajiv Chopra, Kitae Lim, et al.
Molecular Cancer
|
May 21, 2010
NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations
Yi-Ping Fu, Hege Edvardsen, Alpana Kaushiva, et al.
The Journal of the Acoustical Society of America
|
October 15, 2013
The North Pacific Acoustic Laboratory deep-water acoustic propagation experiments in the Philippine Sea
Peter F Worcester, Matthew A Dzieciuch, James A Mercer, et al.
Nature Communications
|
January 30, 2015
Probing electric field control of magnetism using ferromagnetic resonance
Ziyao Zhou, Morgan Trassin, Ya Gao, et al.
Neurology
|
August 11, 2021
Pure Motor Onset and IgM-Gammopathy Occurrence in Multifocal Acquired Demyelinating Sensory and Motor Neuropathy
Grayson Beecher, Shahar Shelly, P James B Dyck, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
|
January 18, 2019
A systematic, deep sequencing-based methodology for identification of mixed-genotype hepatitis C virus infections
Andrea D Olmstead, Vincent Montoya, Celia K Chui, et al.
Scientific Reports
|
January 15, 2014
Quantification of strain and charge co-mediated magnetoelectric coupling on ultra-thin Permalloy/PMN-PT interface
Tianxiang Nan, Ziyao Zhou, Ming Liu, et al.
Scientific Reports
|
September 2, 2016
Non-Volatile Ferroelectric Switching of Ferromagnetic Resonance in NiFe/PLZT Multiferroic Thin Film Heterostructures
Zhongqiang Hu, Xinjun Wang, Tianxiang Nan, et al.
Lancet (London, England)
|
December 4, 2014
Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial
Eric Lawitz, Edward Gane, Brian Pearlman, et al.
Lancet (London, England)
|
December 4, 2014
Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial
Mark Sulkowski, Christophe Hezode, Jan Gerstoft, et al.
Page
of 50